与亡相关的基因预后和治疗效果分析儿童骨髓瘤的骨髓瘤
Yuanling Chen1, Ling Wu1, Yunyan Li1
1Ningbo Women and Children's Hospital, Ningbo, China.
The journal of gene medicine
|December 15, 2023
概括
与亡相关的基因可以预测骨髓瘤患者对化疗和免疫疗法的反应. 这项研究确定了基于这些基因的亚型,改善了预后预测和指导治疗策略.
科学领域:
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 免疫细胞平衡对于癌症研究和治疗反应至关重要.
- 化疗和免疫疗法对骨髓瘤 (OS) 是有希望的,但需要预测患者的反应.
- 亡会影响治疗的有效性,并提供对患者分层的见解.
研究的目的:
- 在骨髓瘤发育中识别与亡相关的基因.
- 将OS患者根据亡基因表达分类为亚型,用于预后和治疗预测.
- 评估风险评分模型,用于预测预后和确定治疗目标.
主要方法:
- 高通量查以识别与亡相关的基因.
- 达成共识的集群使用TARGET-OS和GSE21257数据集将OS患者分类为子类型.
- 预后分析,风险评分模型开发和独立预后因素的识别.
主要成果:
- 确定了92个与亡相关的基因,并将OS患者分为三个亚型.
- 亚型在免疫细胞透,免疫通路和预后方面表现出明显的差异.
- 一个基于名图的签名有效地预测了化疗和免疫疗法的反应,超过了单个临床指标.
结论:
- 与亡相关的基因在骨髓瘤中起着显著的预后作用.
- 这项研究为预后预测和OS的临床管理提供了一种新的方法.
- 这些发现强调了免疫细胞平衡在癌症治疗反应中的重要性.
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


